Akero Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 1,605 $21.7 $34,829
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 5,433 $21.56 $117,135
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 18,582 $19.8 $367,924
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 2,020 $19.5 $39,390
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 7,651 $19.58 $149,807
Option
GRAHAM G. WALMSLEY director
 Stock Option (Right to Buy) 2,168 $19.97 $43,295
Purchase
APPLE TREE PARTNERS IV, L.P. 10 percent owner
 Common Stock 900,000 $16 $14,400,000
Purchase
HARRISON SETH LORING director, 10 percent owner
 Common Stock 900,000 $16 $14,400,000
Purchase
VENBIO GLOBAL STRATEGIC FUND II L.P. 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 400,000 $16 $6,400,000
Purchase
ATLAS VENTURE FUND XI, L.P. 10 percent owner
 Common Stock 270,000 $16 $4,320,000
Purchase
ROYSTON AARON director
 Common Stock 250,000 $16 $4,000,000
Purchase
BITTERMAN KEVIN director
 Common Stock 270,000 $16 $4,320,000

Showing 500 to 513 of 513 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: